Other Species / Isoforms
  NFkB-p65 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K37
RGMRFRYKCEGRSAG
1 0
NFkB-p65 (human) RGMRFRYkCEGRsAG K37-m1
NFkB-p65 (mouse) RGMRFRYKCEGRSAG K37
NFkB-p65 (rat) RGMRFRYKCEGRSAG K37
K37
RGMRFRYKCEGRSAG
2 0
NFkB-p65 (human) RGMRFRYkCEGRsAG K37-me
NFkB-p65 (mouse) RGMRFRYKCEGRSAG K37
NFkB-p65 (rat) RGMRFRYKCEGRSAG K37
S42
RYKCEGRSAGsIPGE
1 3
NFkB-p65 (human) RYkCEGRsAGsIPGE S42-p
NFkB-p65 (mouse) RYKCEGRSAGsIPGE S42
NFkB-p65 (rat) RYKCEGRSAGSIPGE S42
S45-p
CEGRSAGsIPGERST
1 8
NFkB-p65 (human) CEGRsAGsIPGERST S45-p
NFkB-p65 (mouse) CEGRSAGsIPGERST S45-p
NFkB-p65 (rat) CEGRSAGSIPGERST S45
K56
ERSTDTTKTHPTIKI
1 1
NFkB-p65 (human) ERSTDTTkTHPTIkI K56-ub
NFkB-p65 (mouse) ERSTDTTKTHPTIKI K56
NFkB-p65 (rat) ERSTDTTKTHPTIKI K56
K62
TKTHPTIKINGYTGP
2 0
NFkB-p65 (human) TkTHPTIkINGYTGP K62-ub
NFkB-p65 (mouse) TKTHPTIKINGYTGP K62
NFkB-p65 (rat) TKTHPTIKINGYTGP K62
T71
NGYTGPGTVRISLVT
0 1
NFkB-p65 (human) NGYTGPGtVRISLVT T71-p
NFkB-p65 (mouse) NGYTGPGTVRISLVT T71
NFkB-p65 (rat) NGYTGPGTVRISLVT T71
K79
VRISLVTKDPPHRPH
1 0
NFkB-p65 (human) VRISLVTkDPPHRPH K79-ub
NFkB-p65 (mouse) VRISLVTKDPPHRPH K79
NFkB-p65 (rat) VRISLVTKDPPHRPH K79
K93
HPHELVGKDCRDGyY
0 1
NFkB-p65 (human) HPHELVGkDCRDGFY K93-ub
NFkB-p65 (mouse) HPHELVGKDCRDGyY K93
NFkB-p65 (rat) HPHELVGKDCRDGFY K93
Y99-p
GKDCRDGyYEADLCP
0 2
NFkB-p65 (human) GkDCRDGFYEAELCP F99
NFkB-p65 (mouse) GKDCRDGyYEADLCP Y99-p
NFkB-p65 (rat) GKDCRDGFYEAELCP F99
S109-p
ADLCPDRsIHsFQNL
0 1
NFkB-p65 (human) AELCPDRCIHsFQNL C109
NFkB-p65 (mouse) ADLCPDRsIHsFQNL S109-p
NFkB-p65 (rat) AELCPDRCIHSFQNL C109
S112-p
CPDRsIHsFQNLGIQ
0 2
NFkB-p65 (human) CPDRCIHsFQNLGIQ S112-p
NFkB-p65 (mouse) CPDRsIHsFQNLGIQ S112-p
NFkB-p65 (rat) CPDRCIHSFQNLGIQ S112
K122-ac
NLGIQCVkkRDLEQA
Upstream
Downstream
6 26
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • phosphorylation
Effects on Biological Processes:
  • cell differentiation, induced
  • signaling pathway regulation
  • transcription, altered
  • transcription, induced
Treatment
  • LPS
NFkB-p65 (human) NLGIQCVkkRDLEQA K122-ac
NFkB-p65 (mouse) NLGIQCVkkRDLEQA K122-ac
NFkB-p65 (rat) NLGIQCVKKRDLEQA K122
K122
NLGIQCVKkRDLEQA
1 1
NFkB-p65 (human) NLGIQCVkkRDLEQA K122-ub
NFkB-p65 (mouse) NLGIQCVKkRDLEQA K122
NFkB-p65 (rat) NLGIQCVKKRDLEQA K122
K123-ac
LGIQCVkkRDLEQAI
Downstream
4 0
Effects on Modified Protein
  • intracellular localization
  • phosphorylation
Effects on Biological Processes:
  • cell differentiation, induced
  • signaling pathway regulation
  • transcription, altered
NFkB-p65 (human) LGIQCVkkRDLEQAI K123-ac
NFkB-p65 (mouse) LGIQCVkkRDLEQAI K123-ac
NFkB-p65 (rat) LGIQCVKKRDLEQAI K123
K123-ub
LGIQCVkkRDLEQAI
1 1
NFkB-p65 (human) LGIQCVkkRDLEQAI K123-ub
NFkB-p65 (mouse) LGIQCVkkRDLEQAI K123-ub
NFkB-p65 (rat) LGIQCVKKRDLEQAI K123
S131-p
RDLEQAIsQRIQTNN
1 3
NFkB-p65 (human) RDLEQAIsQRIQtNN S131-p
NFkB-p65 (mouse) RDLEQAIsQRIQTNN S131-p
NFkB-p65 (rat) RDLEQAISQRIQTNN S131
T136
AIsQRIQTNNNPFHV
1 1
NFkB-p65 (human) AIsQRIQtNNNPFQV T136-p
NFkB-p65 (mouse) AIsQRIQTNNNPFHV T136
NFkB-p65 (rat) AISQRIQTNNNPFQV T136
L174
DPAGRPLLLtPVLSH
1 1
NFkB-p65 (human) DPSGRPLrLPPVLsH R174-m2
NFkB-p65 (mouse) DPAGRPLLLtPVLSH L174
NFkB-p65 (rat) DPSGRPLRLTPVLSH R174
T176-p
AGRPLLLtPVLSHPI
Upstream
0 4
Treatment
  • insulin
NFkB-p65 (human) SGRPLrLPPVLsHPI P176
NFkB-p65 (mouse) AGRPLLLtPVLSHPI T176-p
NFkB-p65 (rat) SGRPLRLTPVLSHPI T176
S180
LLLtPVLSHPIFDNR
0 2
NFkB-p65 (human) LrLPPVLsHPIFDNr S180-p
NFkB-p65 (mouse) LLLtPVLSHPIFDNR S180
NFkB-p65 (rat) LRLTPVLSHPIFDNR S180
R187
SHPIFDNRAPNTAEL
0 1
NFkB-p65 (human) sHPIFDNrAPNTAEL R187-m1
NFkB-p65 (mouse) SHPIFDNRAPNTAEL R187
NFkB-p65 (rat) SHPIFDNRAPNTAEL R187
K195
APNTAELKICRVNRN
2 1
NFkB-p65 (human) APNTAELkICRVNRN K195-ub
NFkB-p65 (mouse) APNTAELKICRVNRN K195
NFkB-p65 (rat) APNTAELKICRVNRN K195
S203-p
ICRVNRNsGsCLGGD
0 1
NFkB-p65 (human) ICRVNRNSGsCLGGD S203
NFkB-p65 (mouse) ICRVNRNsGsCLGGD S203-p
NFkB-p65 (rat) ICRVNRNSGSCLGGD S203
S205-p
RVNRNsGsCLGGDEI
4 1
NFkB-p65 (human) RVNRNSGsCLGGDEI S205-p
NFkB-p65 (mouse) RVNRNsGsCLGGDEI S205-p
NFkB-p65 (rat) RVNRNSGSCLGGDEI S205
K218-ac
EIFLLCDkVQkEDIE
6 0
NFkB-p65 (human) EIFLLCDkVQkEDIE K218-ac
NFkB-p65 (mouse) EIFLLCDkVQkEDIE K218-ac
NFkB-p65 (rat) EIFLLCDKVQKEDIE K218
K218
EIFLLCDKVQkEDIE
1 0
NFkB-p65 (human) EIFLLCDkVQkEDIE K218-me
NFkB-p65 (mouse) EIFLLCDKVQkEDIE K218
NFkB-p65 (rat) EIFLLCDKVQKEDIE K218
K221-ac
LLCDkVQkEDIEVYF
10 0
NFkB-p65 (human) LLCDkVQkEDIEVYF K221-ac
NFkB-p65 (mouse) LLCDkVQkEDIEVYF K221-ac
NFkB-p65 (rat) LLCDKVQKEDIEVYF K221
K221
LLCDkVQKEDIEVYF
1 0
NFkB-p65 (human) LLCDkVQkEDIEVYF K221-me
NFkB-p65 (mouse) LLCDkVQKEDIEVYF K221
NFkB-p65 (rat) LLCDKVQKEDIEVYF K221
S238-p
PGWEARGsFSQADVH
Upstream
1 10
Treatment
  • insulin
  • MK-2206
NFkB-p65 (human) PGWEARGsFSQADVH S238-p
NFkB-p65 (mouse) PGWEARGsFSQADVH S238-p
NFkB-p65 (rat) PGWEARGSFSQADVH S238
T254
QVAIVFRTPPYADPs
3 1
NFkB-p65 (human) QVAIVFRtPPYADPs T254-p
NFkB-p65 (mouse) QVAIVFRTPPYADPs T254
NFkB-p65 (rat) QVAIVFRtPPyADPS T254-p
Y257
IVFRTPPYADPsLQA
0 1
NFkB-p65 (human) IVFRtPPYADPsLQA Y257
NFkB-p65 (mouse) IVFRTPPYADPsLQA Y257
NFkB-p65 (rat) IVFRtPPyADPSLQA Y257-p
S261-p
TPPYADPsLQAPVRV
1 2
NFkB-p65 (human) tPPYADPsLQAPVRV S261-p
NFkB-p65 (mouse) TPPYADPsLQAPVRV S261-p
NFkB-p65 (rat) tPPyADPSLQAPVRV S261
S269
LQAPVRVSMQLRRPs
1 1
NFkB-p65 (human) LQAPVRVsMQLRRPs S269-p
NFkB-p65 (mouse) LQAPVRVSMQLRRPs S269
NFkB-p65 (rat) LQAPVRVSMQLRRPs S269
S276-p
SMQLRRPsDRELSEP
Upstream
Downstream
71 0
Effects on Modified Protein
  • acetylation
  • activity, induced
  • molecular association, regulation
  • protein degradation
  • protein processing
Effects on Biological Processes:
  • apoptosis, altered
  • cell differentiation, altered
  • transcription, altered
  • transcription, induced
Kinase, in vitro:
  • MSK1 (human)
  • PKACA (human)
  • PKACA (mouse)
Putative in vivo kinases:
  • MSK1 (mouse)
  • PKACA (mouse)
Regulatory protein:
  • Cot (mouse)
  • MKK6 (mouse)
  • TAK1 (mouse)
  • TICAM1 (mouse)
  • TLR4 (mouse)
  • TRAF6 (mouse)
Treatment
  • beta-amyloid_40
  • bisindolylmaleimide
  • deferoxamine
  • echinatin
  • GW_5074
  • IL-8
  • injury
  • isoliquiritigenin
  • KT5720
  • licochalcone_A
  • licochalcone_B
  • licochalcone_C
  • licochalcone_D
  • LPS
  • NS398
  • NSC-127102
  • OH-BBN
  • peptidoglycan
  • RANKL
  • Ro31-8220
  • SB203580
  • silibinin
  • silymarin
  • Tat
  • TNF
  • virus infection
NFkB-p65 (human) sMQLRRPsDRELsEP S276-p
NFkB-p65 (mouse) SMQLRRPsDRELSEP S276-p
NFkB-p65 (rat) SMQLRRPsDRELSEP S276-p
S281
RPsDRELSEPMEFQY
5 0
NFkB-p65 (human) RPsDRELsEPMEFQY S281-p
NFkB-p65 (mouse) RPsDRELSEPMEFQY S281
NFkB-p65 (rat) RPsDRELSEPMEFQY S281
T305
IEEKRKRTYETFksI
1 2
NFkB-p65 (human) IEEKRKRtyEtFksI T305-p
NFkB-p65 (mouse) IEEKRKRTYETFksI T305
NFkB-p65 (rat) IEEKRKRTYETFksI T305
T305
IEEKRKRTYETFksI
2 1
NFkB-p65 (human) IEEKRKRtyEtFksI T305-gl
NFkB-p65 (mouse) IEEKRKRTYETFksI T305
NFkB-p65 (rat) IEEKRKRTYETFksI T305
Y306
EEKRKRTYETFksIM
0 2
NFkB-p65 (human) EEKRKRtyEtFksIM Y306-p
NFkB-p65 (mouse) EEKRKRTYETFksIM Y306
NFkB-p65 (rat) EEKRKRTYETFksIM Y306
T308
KRKRTYETFksIMKK
1 2
NFkB-p65 (human) KRKRtyEtFksIMkk T308-p
NFkB-p65 (mouse) KRKRTYETFksIMKK T308
NFkB-p65 (rat) KRKRTYETFksIMKK T308
K310-ac
KRTYETFksIMKKSP
Upstream
Downstream
51 5
NFkB-p65 (human)
K310-ac
NFkB-p65 (mouse)
K310-ac
NFkB-p65 (rat)
K310-ac
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell differentiation, inhibited
  • signaling pathway regulation
  • transcription, altered
  • transcription, induced
Treatment
  • aurentiacin
  • bacterial infection
  • LPS
  • siRNA
  • SRT1720
  • TNF
  • trichostatin_A
  • vorinostat
NFkB-p65 (human) KRtyEtFksIMkksP K310-ac
NFkB-p65 (mouse) KRTYETFksIMKKSP K310-ac
NFkB-p65 (rat) KRTYETFksIMKKSP K310-ac
K310
KRTYETFKsIMKKSP
2 0
NFkB-p65 (human)
K310-m1
NFkB-p65 (mouse)
K310-m1
NFkB-p65 (rat)
K310-m1
NFkB-p65 (human) KRtyEtFksIMkksP K310-m1
NFkB-p65 (mouse) KRTYETFKsIMKKSP K310
NFkB-p65 (rat) KRTYETFKsIMKKSP K310
K310
KRTYETFKsIMKKSP
1 1
NFkB-p65 (human) KRtyEtFksIMkksP K310-ub
NFkB-p65 (mouse) KRTYETFKsIMKKSP K310
NFkB-p65 (rat) KRTYETFKsIMKKSP K310
S311-p
RTYETFksIMKKSPF
Upstream
Downstream
13 2
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, inhibited
  • transcription, induced
Kinase, in vitro:
  • PKCZ (mouse)
Putative in vivo kinases:
  • PKCZ (mouse)
Treatment
  • TNF
NFkB-p65 (human) RtyEtFksIMkksPF S311-p
NFkB-p65 (mouse) RTYETFksIMKKSPF S311-p
NFkB-p65 (rat) RTYETFksIMKKSPF S311-p
K314
ETFksIMKKSPFNGP
4 1
NFkB-p65 (human) EtFksIMkksPFsGP K314-ac
NFkB-p65 (mouse) ETFksIMKKSPFNGP K314
NFkB-p65 (rat) ETFksIMKKSPFNGP K314
K314
ETFksIMKKSPFNGP
2 0
NFkB-p65 (human) EtFksIMkksPFsGP K314-m1
NFkB-p65 (mouse) ETFksIMKKSPFNGP K314
NFkB-p65 (rat) ETFksIMKKSPFNGP K314
K314
ETFksIMKKSPFNGP
1 0
NFkB-p65 (human) EtFksIMkksPFsGP K314-ub
NFkB-p65 (mouse) ETFksIMKKSPFNGP K314
NFkB-p65 (rat) ETFksIMKKSPFNGP K314
K315
TFksIMKKSPFNGPT
4 1
NFkB-p65 (human) tFksIMkksPFsGPt K315-ac
NFkB-p65 (mouse) TFksIMKKSPFNGPT K315
NFkB-p65 (rat) TFksIMKKSPFNGPT K315
K315
TFksIMKKSPFNGPT
2 0
NFkB-p65 (human) tFksIMkksPFsGPt K315-m1
NFkB-p65 (mouse) TFksIMKKSPFNGPT K315
NFkB-p65 (rat) TFksIMKKSPFNGPT K315
K315
TFksIMKKSPFNGPT
1 1
NFkB-p65 (human) tFksIMkksPFsGPt K315-ub
NFkB-p65 (mouse) TFksIMKKSPFNGPT K315
NFkB-p65 (rat) TFksIMKKSPFNGPT K315
S316
FksIMKKSPFNGPTE
1 3
NFkB-p65 (human) FksIMkksPFsGPtD S316-p
NFkB-p65 (mouse) FksIMKKSPFNGPTE S316
NFkB-p65 (rat) FksIMKKSPFNGPTE S316
N319
IMKKSPFNGPTEPRP
1 1
NFkB-p65 (human) IMkksPFsGPtDPRP S319-gl
NFkB-p65 (mouse) IMKKSPFNGPTEPRP N319
NFkB-p65 (rat) IMKKSPFNGPTEPRP N319
T322
KSPFNGPTEPRPPTR
3 1
NFkB-p65 (human) ksPFsGPtDPRPPPR T322-gl
NFkB-p65 (mouse) KSPFNGPTEPRPPTR T322
NFkB-p65 (rat) KSPFNGPTEPRPPPR T322
N337
RIAVPTRNSTSVPKP
1 1
NFkB-p65 (human) RIAVPSRsSASVPKP S337-gl
NFkB-p65 (mouse) RIAVPTRNSTSVPKP N337
NFkB-p65 (rat) RIAVPSRGPTSVPKP G337
P352
APQPYTFPASLSTIN
3 1
NFkB-p65 (human) APQPYPFtSSLSTIN T352-gl
NFkB-p65 (mouse) APQPYTFPASLSTIN P352
NFkB-p65 (rat) APQPYAFSTSLSTIN S352
S374
LLPSGQISNQALALA
1 1
NFkB-p65 (human) VFPSGQIsQAsALAP S374-gl
NFkB-p65 (mouse) LLPSGQISNQALALA S374
NFkB-p65 (rat) VLPPGQISNQALALA S374
L378
GQISNQALALAPSSA
1 1
NFkB-p65 (human) SGQIsQAsALAPAPP S377-gl
NFkB-p65 (mouse) GQISNQALALAPSSA L378
NFkB-p65 (rat) GQISNQALALAPSSA L378
T433
STQAGEGTLSEALLH
2 0
NFkB-p65 (human) PTQAGEGtLSEALLQ T435-p
NFkB-p65 (mouse) STQAGEGTLSEALLH T433
NFkB-p65 (rat) STQAGEGTLSEALLH T434
S467-p
GVFTDLAsVDNSEFQ
Upstream
Downstream
15 0
NFkB-p65 (human)
S468-p
NFkB-p65 (mouse)
S467-p
NFkB-p65 (rat)
S468-p
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, induced
  • transcription, inhibited
  • translation, induced
Kinase, in vitro:
  • IKKB (human)
NFkB-p65 (human) AVFTDLAsVDNsEFQ S468-p
NFkB-p65 (mouse) GVFTDLAsVDNSEFQ S467-p
NFkB-p65 (rat) GVFTDLAsVDNSEFQ S468-p
S471
DLAsVDNSEFQQLLN
1 1
NFkB-p65 (human) DLAsVDNsEFQQLLN S472-p
NFkB-p65 (mouse) DLAsVDNSEFQQLLN S471
NFkB-p65 (rat) DLAsVDNSEFQQLLN S472
T504-p
EAITRLVtGSQRPPD
Downstream
4 0
Effects on Biological Processes:
  • cell motility, inhibited
NFkB-p65 (human) EAITRLVtGAQRPPD T505-p
NFkB-p65 (mouse) EAITRLVtGSQRPPD T504-p
NFkB-p65 (rat) EAITRLVTGSQRPPD T505
S527-p
SGLPNGLsGDEDFss
Upstream
16 3
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
NFkB-p65 (human) GLPNGLLsGDEDFSs S529-p
NFkB-p65 (mouse) SGLPNGLsGDEDFss S527-p
NFkB-p65 (rat) SGLPNGLsGDEDFSs S528-p
S533-p
LsGDEDFssIADMDF
0 1
NFkB-p65 (human) LsGDEDFSsIADMDF S535
NFkB-p65 (mouse) LsGDEDFssIADMDF S533-p
NFkB-p65 (rat) LsGDEDFSsIADMDF S534
S534-p
sGDEDFssIADMDFS
Upstream
Downstream
140 4
NFkB-p65 (human)
S536-p
NFkB-p65 (mouse)
S534-p
NFkB-p65 (rat)
S535-p
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
  • protein degradation
  • protein processing
Effects on Biological Processes:
  • carcinogenesis, induced
  • signaling pathway regulation
  • transcription, altered
  • transcription, induced
  • transcription, inhibited
Kinase, in vitro:
  • IKKA (human)
  • IKKA (mouse)
  • IKKB (human)
  • IKKB (mouse)
Putative in vivo kinases:
  • IKKA (human)
  • IKKA (mouse)
  • IKKB (human)
  • IKKB (mouse)
  • IKKE (human)
Putative upstream phosphatases:
  • PPM1D (mouse)
Regulatory protein:
  • Akt1 (human)
  • ARHGEF2 (mouse)
  • Btk (mouse)
  • CARD9 (mouse)
  • dectin-1 (mouse)
  • GPX1 (mouse)
  • IkB-alpha (mouse)
  • IKKB (mouse)
  • IKKE (mouse)
  • ILK (mouse)
  • ITGB3 (mouse)
  • MIEN1 (human)
  • MKK6 (mouse)
  • RGN (mouse)
  • TAK1 (mouse)
  • TSC2 (mouse)
Treatment
  • 4-HT
  • [6]-gingerol
  • AAPH
  • aurentiacin
  • bacterial infection
  • benzo(a)pyrene
  • beta-amyloid_42
  • bortezomib
  • calyculin_A
  • cilengitide
  • cpd22
  • CpG
  • curdlan
  • double-stranded_RNA
  • GSK-3_inhibitor_X
  • guanosine
  • IFN-gamma
  • IKK-beta_inhibitor_IV
  • IL-10
  • IL-1b
  • IL-8
  • IMD-0354
  • ischemia
  • licochalcone_A
  • licochalcone_B
  • licochalcone_C
  • licochalcone_D
  • LPS
  • LY294002
  • MMS
  • NBD_peptide
  • NSC-87877
  • NTCU
  • OH-BBN
  • PF 573228
  • PHA-665752
  • phorbol_ester
  • pomegranate_wine
  • RANKL
  • resiquimod
  • SB203580
  • SC-514
  • silibinin
  • silymarin
  • skin aging
  • TGF-beta
  • TNF
  • UVB
  • virus infection
NFkB-p65 (human) sGDEDFSsIADMDFS S536-p
NFkB-p65 (mouse) sGDEDFssIADMDFS S534-p
NFkB-p65 (rat) sGDEDFSsIADMDFS S535-p
S545-p
MDFSALLsQISS___
Upstream
1 1
Kinase, in vitro:
  • IKKB (human)
NFkB-p65 (human) MDFSALLsQISS___ S547-p
NFkB-p65 (mouse) MDFSALLsQISS___ S545-p
NFkB-p65 (rat) MDFSALLSQISS___ S546